1. Creagh T, Ruckle JL, Tolbert DT, et al. Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects. Antimicrob Agents Chemother . 2001;45:1379-1386. PubMed
2. Shenon P. Hunt in forests of Borneo aims to track down natural drugs. New York Times . 1994 Dec 6.
3. McKee T, et al. Pyranocoumarins from tropical species of the genus Calophyllum : A chemotaxonomic study of extracts in the National Cancer Institute Collection. J Nat Prod . 1998;61:1252-56. PubMed
4. Anonymous. Arnold Arboretum launches $8.2M capital campaign. The Harvard University Gazette . 1996 Jul 3.
5. McKee T, et al. New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii . J Nat Prod . 1996;59:754–58. PubMed
6. Kashman Y, et al. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum . J Med Chem . 1992;35(15):2735-43. PubMed
7. Galinis D, et al. Structure-activity modifications of the HIV-1 inhibitors (+)- calanolide A and (-)-calanolide B. J Med Chem . 1996;39(22):4507-10. PubMed
8. Boyd M, et al. Extraction of calanolide antiviral compounds from Calophyllum . US Pat Appl 1993 #Pat-appl-7-861 249, 1993.
9. Boyd M, et al. Calanolide and related antiretroviral compounds isolated from Calophyllum . 30 pp cont-in-part of US Patent Ser No. 861, 249, 1997.
10. Zembower D, et al. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-0l ring (ring C). J Med Chem . 1997;40(6):1005-17. PubMed
11. Flavin M, et al. Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomers. J Med Chem . 1996;39(6):1303-13. PubMed
12. Hizi A, et al. Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors. Antimicrob Agents Chemother . 1993;37(5):1037-42. PubMed
13. Currens M, et al. Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1. J Pharmacol Exp Ther . 1996;279(2):645-51. PubMed
14. Currens M, et al. Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A. J Pharmacol Exp Ther . 1996;279(2):652-61. PubMed
15. Boyer P, et al. Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. J Virol . 1993;67(4):2412-20. PubMed
16. Buckheit R Jr, et al. Resistance to 1\N\[(2\Nhydroxyethoxy) methyl]-6-(phenylthio) thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase. Virology . 1995;210(1):186-93. PubMed
17. Fuller R, et al. HIV-inhibitory natural products. 16. HIV-inhibitory coumarins from latex of the tropical rain forest tree Calophyllum teysmannii var. inophylloide. Bioorg Med Chem Lett . 1994;4(16):1961-64.
18. Buckheit R Jr, et al. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide. Antimicrob Agents Chemother . 1999;43(8):1827-34. PubMed
19. Dharmaratne H, et al. Inhibition of human immunodeficiency virus type 1 reverse transcriptase activity by cordatolides isolated from Calophyllum cordato-oblongum . Planta Med . 1998;64(5):460-61. PubMed
20. Xu Z, et al. In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI. Bioorg Med Chem Lett . 1998;8(16):2179-84. PubMed
21. Newman R, et al. Pharmaceutical properties of related calanolide compounds with activity against human immunodeficiency virus. J Pharm Sci . 1998;87(9):1077-80. PubMed
22. Matthee G, et al. HIV reverse transcriptase inhibitors of natural origin. Planta Med . 1999;65(6):493-506. PubMed
23. Xu Z, et al. In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse model. Bioorg Med Chem Lett . 1999;9(2):133-38. PubMed